Rhone Ma Holdings Bhd

KLSE:5278 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$33.72 Million
RM151.89 Million MYR
Market Cap Rank
#31851 Global
#712 in Malaysia
Share Price
RM0.69
Change (1 day)
-0.72%
52-Week Range
RM0.60 - RM0.72
All Time High
RM1.04
About

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more

Rhone Ma Holdings Bhd - Asset Resilience Ratio

Latest as of December 2024: 0.13%

Rhone Ma Holdings Bhd (5278) has an Asset Resilience Ratio of 0.13% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
RM282.85K
Cash + Short-term Investments
Total Assets
RM225.24 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Rhone Ma Holdings Bhd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Rhone Ma Holdings Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents RM0.00 0%
Short-term Investments RM282.85K 0.13%
Total Liquid Assets RM282.85K 0.13%

Asset Resilience Insights

  • Limited Liquidity: Rhone Ma Holdings Bhd maintains only 0.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Rhone Ma Holdings Bhd Industry Peers by Asset Resilience Ratio

Compare Rhone Ma Holdings Bhd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Rhone Ma Holdings Bhd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Rhone Ma Holdings Bhd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.13% RM282.85K RM225.45 Million +0.01pp
2023-12-31 0.12% RM273.04K RM230.59 Million -1.05pp
2022-12-31 1.17% RM2.56 Million RM219.43 Million -1.17pp
2021-12-31 2.34% RM4.58 Million RM195.81 Million -0.08pp
2020-12-31 2.42% RM4.51 Million RM185.99 Million --
pp = percentage points